DOI:
10.1055/s-00000031
Klinische Monatsblätter für Augenheilkunde
LinksClose Window
References
Spielberg L, Leys A.
Treatment of neovascular age-related macular degeneration with a variable ranibizumab dosing regimen and one-time reduced-fluence photodynamic therapy: the TORPEDO trial at 2 years.
Graefes Arch Clin Exp Ophthalmol 2010;
248: 943-956
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.